Medical technology giant Zimmer Biomet Holdings announced on Thursday that its board of directors has officially declared a regular quarterly cash dividend of $0.24 per share.

The upcoming payout will be distributed to eligible stockholders of record, reflecting the corporation's steady operational performance and disciplined capital allocation strategy amid evolving global healthcare markets.

Market analysts regard the consistent dividend declaration as a reliable indicator of the company's strong cash flow and enduring pledge to maximize shareholder value.